Works about HER2 gene

Results: 945

Molecular and immunohistochemical characterization of ERBB2 activating mutations in low‐grade serous ovarian carcinoma.

Published in:

Histopathology, 2025, v. 87, n. 2, p. 310, doi. 10.1111/his.15452

By:

Neil, Alexander J;
Nkosi, Dingani;
Yoon, Ju‐Yoon;
Kolin, David L;
Sholl, Lynette M

Publication type:

Article

FICTION Technique—A Candidate for the Assessment of HER2 Status in Breast Invasive Carcinomas.

Published in:

Medicina (1010660X), 2025, v. 61, n. 6, p. 1069, doi. 10.3390/medicina61061069

By:

Fetica, Bogdan;
Blaga, Mihaiela Luminita;
Trifa, Adrian Pavel;
Bocean, Cosmina Maria;
Balacescu, Ovidiu;
Fulop, Annamaria;
Pop, Bogdan

Publication type:

Article

Gene Copy Number Dictates Extracellular Vesicle Cargo.

Published in:

International Journal of Molecular Sciences, 2025, v. 26, n. 12, p. 5496, doi. 10.3390/ijms26125496

By:

Poudel, Sumeet;
He, Zhiyong;
Izac, Jerilyn;
Wang, Lili

Publication type:

Article

HER2 in Non-Small Cell Lung Cancer (NSCLC): Evolution of the Therapeutic Landscape and Emerging Drugs—A Long Way to the Top.

Published in:

Molecules, 2025, v. 30, n. 12, p. 2645, doi. 10.3390/molecules30122645

By:

Trillo Aliaga, Pamela;
Spitaleri, Gianluca;
Attili, Ilaria;
Corvaja, Carla;
Battaiotto, Elena;
Angelopoulos, Panagiotis Agisilaos;
Del Signore, Ester;
Passaro, Antonio;
de Marinis, Filippo

Publication type:

Article

Brain metastasis in gastroesophageal adenocarcinoma and HER2 status.

Published in:

Journal of Neuro-Oncology, 2018, v. 138, n. 2, p. 315, doi. 10.1007/s11060-018-2798-4

By:

Limon, Dror;
Gal, Omer;
Gordon, Noa;
Katz, Lior;
Perl, Gali;
Purim, Ofer;
Amit, Limor;
Stemmer, Salomon M.;
Kundel, Yulia;
Ben-Aharon, Irit;
Brenner, Baruch;
Siegal, Tali;
Yust-Katz, Shlomit

Publication type:

Article

Is there a role of breast pathologist in diagnostic challenges of discordances in ER, PR, and HER2 between primary breast cancer and brain metastasis?

Published in:

2018

By:

Altundag, Kadri

Publication type:

Letter to the Editor

Her2 positive subtype and breast cancer brain metastasis: any effect of anti-Her2 targeted therapy?

Published in:

2017

By:

Altundag, Kadri

Publication type:

Letter

Radio-sensitising effect of T-DM1 should not be discarded for the efficacy of radiosurgery in the management of brain metastases in patients with HER2-positive metastatic breast cancer.

Published in:

2017

By:

Altundag, Kadri

Publication type:

Letter

PI3K pathway inhibitors for the treatment of brain metastases with a focus on HER2+ breast cancer.

Published in:

Journal of Neuro-Oncology, 2014, v. 117, n. 1, p. 7, doi. 10.1007/s11060-014-1369-6

By:

Peddi, Parvin;
Hurvitz, Sara

Publication type:

Article

Breast cancer brain metastases responding to primary systemic therapy with T-DM1.

Published in:

2014

By:

Bartsch, Rupert;
Berghoff, Anna;
Preusser, Matthias

Publication type:

Letter

The effect of tumor subtype on the time from primary diagnosis to development of brain metastases and survival in patients with breast cancer.

Published in:

Journal of Neuro-Oncology, 2013, v. 112, n. 3, p. 467, doi. 10.1007/s11060-013-1083-9

By:

Sperduto, Paul;
Kased, Norbert;
Roberge, David;
Chao, Samuel;
Shanley, Ryan;
Luo, Xianghua;
Sneed, Penny;
Suh, John;
Weil, Robert;
Jensen, Ashley;
Brown, Paul;
Shih, Helen;
Kirkpatrick, John;
Gaspar, Laurie;
Fiveash, John;
Chiang, Veronica;
Knisely, Jonathan;
Sperduto, Christina;
Lin, Nancy;
Mehta, Minesh

Publication type:

Article

Whole-genomic survey of oligodendroglial tumors: correlation between allelic imbalances and gene expression profiles.

Published in:

Journal of Neuro-Oncology, 2011, v. 103, n. 1, p. 71, doi. 10.1007/s11060-010-0369-4

By:

Ferrer-Luna, Rubén;
Núñez, Lina;
Piquer, José;
Arias, Eugenia;
Dasí, Francisco;
Cervio, Andrés;
Arakaki, Naomi;
Sevlever, Gustavo;
Celda, Bernardo;
Martinetto, Horacio

Publication type:

Article

Glioblastoma-derived spheroid cultures as an experimental model for analysis of EGFR anomalies.

Published in:

Journal of Neuro-Oncology, 2011, v. 102, n. 3, p. 395, doi. 10.1007/s11060-010-0352-0

By:

Witusik-Perkowska, Monika;
Rieske, Piotr;
Hułas-Bigoszewska, Krystyna;
Zakrzewska, Magdalena;
Stawski, Robert;
Kulczycka-Wojdala, Dominika;
Bieńkowski, Michał;
Stoczyńska-Fidelus, Ewelina;
Grešner, Sylwia;
Piaskowski, Sylwester;
Jaskólski, Dariusz;
Papierz, Wielisław;
Zakrzewski, Krzysztof;
Kolasa, Maciej;
Ironside, James;
Liberski, Paweł

Publication type:

Article

The role of sphingosine kinase-1 in EGFRvIII-regulated growth and survival of glioblastoma cells.

Published in:

Journal of Neuro-Oncology, 2011, v. 102, n. 3, p. 353, doi. 10.1007/s11060-010-0345-z

By:

Estrada-Bernal, Adriana;
Lawler, Sean;
Nowicki, Michal;
Ray Chaudhury, Abhik;
Van Brocklyn, James

Publication type:

Article

Association between the HER2 expression and histological differentiation in Wilms tumor.

Published in:

2006

By:

Salem, M.;
Kinoshita, Y.;
Tajiri, T.;
Souzaki, R.;
Tatsuta, K.;
Higashi, M.;
Izaki, T.;
Kohashi, K.;
Tsuneyoshi, M.;
Taguchi, T.

Publication type:

journal article

Highly efficient production of anti-HER2 scFv antibody variant for targeting breast cancer cells.

Published in:

Applied Microbiology & Biotechnology, 2011, v. 91, n. 3, p. 613, doi. 10.1007/s00253-011-3306-3

By:

Sommaruga, Silvia;
Lombardi, Alessio;
Salvadè, Agnese;
Mazzucchelli, Serena;
Corsi, Fabio;
Galeffi, Patrizia;
Tortora, Paolo;
Prosperi, Davide

Publication type:

Article

HER-2, polymorphismes génétiques et cancer du sein.

Published in:

Oncologie (Tech Science Press), 2008, v. 10, n. 1, p. 37, doi. 10.1007/s10269-007-0792-0

By:

Milano, G.

Publication type:

Article

Retrospective Analysis of Risk Factors for Central Nervous System Metastases in Operable Breast Cancer: Effects of Biologic Subtype and Ki67 Overexpression on Survival.

Published in:

Oncology, 2013, v. 84, n. 3, p. 135, doi. 10.1159/000345321

By:

Ishihara, Mikiya;
Mukai, Hirofumi;
Nagai, Shunji;
Onozawa, Masakatsu;
Nihei, Keiji;
Shimada, Toshiyuki;
Wada, Noriaki

Publication type:

Article

Hormonal Receptor, Human Epidermal Growth Factor Receptor-2, and Ki67 Discordance between Primary Breast Cancer and Paired Metastases: Clinical Impact.

Published in:

Oncology, 2013, v. 84, n. 3, p. 150, doi. 10.1159/000345795

By:

Ibrahim, Toni;
Farolfi, alberto;
Scarpi, Emanuela;
Mercatali, Laura;
Medri, Laura;
Ricci, Marianna;
Nanni, Oriana;
Serra, Luigi;
amadori, Dino

Publication type:

Article

Targeted HER2 Treatment in Advanced Gastric Cancer.

Published in:

Oncology, 2010, v. 78, n. 1, p. 26, doi. 10.1159/000288295

By:

Jørgensen, Jan Trøst

Publication type:

Article

Comparison of lymph node metastasis rates in breast cancer molecular subtypes; A retrospective clinical study.

Published in:

Medicine Science, 2023, v. 12, n. 1, p. 52, doi. 10.5455/medscience.2022.11.233

By:

Esen, Ebru;
Saydam, Mehmet;
Guler, Sumeyra;
Yilmaz, Kerim Bora;
Turan, Mujdat;
Demir, Pervin;
Gulcelik, Mehmet Ali

Publication type:

Article

Commentary: on Trastuzumab deruxtecan in the treatment of adult patients with HER-positive breast cancer.

Published in:

Oncology in Clinical Practice (2450-1654), 2023, v. 19, n. 5, p. 382, doi. 10.5603/ocp.97613

By:

Krzakowski, Maciej

Publication type:

Article

HER2-low -- the new subtype of breast cancer?

Published in:

Oncology in Clinical Practice (2450-1654), 2022, v. 18, n. 4, p. 257, doi. 10.5603/OCP.2022.0001

By:

Pogoda, Katarzyna;
Jagiełło-Gruszfeld, Agnieszka;
Nowecki, Zbigniew

Publication type:

Article

Does HER-2 over-expression improves the outcome of axilla down-staging in node positive invasive breast cancer?

Published in:

Nowotwory, 2018, v. 68, p. 18, doi. 10.5603/NJO.2018.0001

By:

Abdalla Al-Zawi, A. Saad

Publication type:

Article

Trastuzumab as adjuvant treatment for early stage HER2-positive breast cancer — a 10 year history.

Published in:

Nowotwory, 2016, v. 66, n. 6, p. 477, doi. 10.5603/NJO.2016.0085

By:

Radecka, Barbara

Publication type:

Article

HER2 Expression in Peritoneal Dissemination of High-Grade Serous Ovarian Carcinoma: A Comparative Study of Immunohistochemical Reactivity Using Four HER2 Antibodies.

Published in:

Journal of Clinical Medicine, 2022, v. 11, n. 23, p. 6963, doi. 10.3390/jcm11236963

By:

Yeo, Min-Kyung;
Kim, Sup;
Yoo, Heon Jong;
Suh, Kwang-Sun;
Kim, Kyung-Hee

Publication type:

Article

Triple Negative Breast Cancer: An Analysis of the Subtypes and the Effects of Menopausal Status on Invasive Breast Cancer.

Published in:

Journal of Clinical Medicine, 2022, v. 11, n. 9, p. 2331, doi. 10.3390/jcm11092331

By:

Nishimura, Reiki;
Osako, Tomofumi;
Okumura, Yasuhiro;
Nakano, Masahiro;
Otsuka, Hiroko;
Fujisue, Mamiko;
Arima, Nobuyuki

Publication type:

Article

<sup>18</sup>F-FDG PET/CT of advanced gastric carcinoma and association of HER2 expression with standardized uptake value.

Published in:

Asia Oceania Journal of Nuclear Medicine & Biology, 2014, v. 2, n. 1, p. 12

By:

Jin Suk Kim;
Shin Young Park

Publication type:

Article

Integrative investigation on breast cancer in ER, PR and HER2-defined subgroups using mRNA and miRNA expression profiling.

Published in:

Scientific Reports, 2014, p. 1, doi. 10.1038/srep06566

By:

Xiaofeng Dai;
Chen, Ana;
Zhonghu Bai

Publication type:

Article

Gene amplification and overexpression of HER2 in renal cell carcinoma.

Published in:

BJU International, 2002, v. 89, n. 1, p. 5, doi. 10.1046/j.1464-410X.2002.02526.x

By:

Latif, Z.;
Watters, A.D.;
Bartlett, J.M.S.;
Underwood, M.A.;
Aitchison, M.

Publication type:

Article

Gene Expression Profiling for Diagnosis of Triple-Negative Breast Cancer: A Multicenter, Retrospective Cohort Study.

Published in:

Frontiers in Oncology, 2019, p. N.PAG, doi. 10.3389/fonc.2019.00354

By:

Wang, Qifeng;
Xu, Midie;
Sun, Yifeng;
Chen, Jinying;
Chen, Chengshu;
Qian, Chenhui;
Chen, Yizuo;
Cao, Liyu;
Xu, Qinghua;
Du, Xiang;
Yang, Wentao

Publication type:

Article

Detection of ERBB2 (HER2) Gene Amplification Events in Cell-Free DNA and Response to Anti-HER2 Agents in a Large Asian Cancer Patient Cohort.

Published in:

Frontiers in Oncology, 2019, p. N.PAG, doi. 10.3389/fonc.2019.00212

By:

Lee, Jeeyun;
Franovic, Aleksandra;
Shiotsu, Yukimasa;
Kim, Seung Tae;
Kim, Kyoung-Mee;
Banks, Kimberly C.;
Raymond, Victoria M.;
Lanman, Richard B.

Publication type:

Article

Current Landscape of Targeted Therapies for Hormone-Receptor Positive, HER2 Negative Metastatic Breast Cancer.

Published in:

Frontiers in Oncology, 2018, p. N.PAG, doi. 10.3389/fonc.2018.00308

By:

Ballinger, Tarah J.;
Meier, Jason B.;
Jansen, Valerie M.

Publication type:

Article

Efficacy of Anti-HER2 Agents in Combination With Adjuvant or Neoadjuvant Chemotherapy for Early and Locally Advanced HER2-Positive Breast Cancer Patients: A Network Meta-Analysis.

Published in:

Frontiers in Oncology, 2018, p. 1, doi. 10.3389/fonc.2018.00156

By:

Debiasi, Márcio;
Polanczyk, Carisi A.;
Ziegelmann, Patrícia;
Barrios, Carlos;
Hongyuan Cao;
Dignam, James J.;
Goss, Paul;
Bychkovsky, Brittany;
Finkelstein, Dianne M.;
Guindalini, Rodrigo S.;
Filho, Paulo;
Albuquerque, Caroline;
Reinert, Tomás;
de Azambuja, Evandro;
Olopade, Olufunmilayo

Publication type:

Article

Pathologic Complete Response of HER-2 Neu-Positive Invasive Ductal Carcinoma and Ductal Carcinoma In Situ following Neoadjuvant Chemotherapy plus Trastuzumab: A Case Report and Review of Literature.

Published in:

Case Reports in Surgery, 2012, p. 1, doi. 10.1155/2012/454273

By:

Gunia, Sommer R.;
Patel, Mita S.;
Mamounas, Eleftherios P.

Publication type:

Article

Clinical Features of Male Breast Cancer: Experiences from Seven Institutions Over 20 Years.

Published in:

Cancer Research & Treatment, 2016, v. 48, n. 4, p. 1389, doi. 10.4143/crt.2015.410

By:

Ji Hyung Hong;
Kyung Sun Ha;
Yun Hwa Jung;
Hye Sung Won;
Ho Jung An;
Guk Jin Lee;
Donghoon Kang;
Ji Chan Park;
Sarah Park;
Jae Ho Byun;
Young Jin Suh;
Jeong Soo Kim;
Woo Chan Park;
Sang Seol Jung;
Il Young Park;
Su-Mi Chung;
In Sook Woo

Publication type:

Article

Prognostic Value of Axillary Nodal Ratio after Neoadjuvant Chemotherapy of Doxorubicin/Cyclophosphamide Followed by Docetaxel in Breast Cancer: A Multicenter Retrospective Cohort Study.

Published in:

Cancer Research & Treatment, 2016, v. 48, n. 4, p. 1373, doi. 10.4143/crt.2015.475

By:

Se Hyun Kim;
Kyung Hae Jung;
Tae-Yong Kim;
Seock-Ah Im;
In Sil Choi;
Yee Soo Chae;
Sun Kyung Baek;
Seok Yun Kang;
Sarah Park;
In Hae Park;
Keun Seok Lee;
Yoon Ji Choi;
Soohyeon Lee;
Joo Hyuk Sohn;
Yeon-Hee Park;
Young-Hyuck Im;
Jin-Hee Ahn;
Sung-Bae Kim;
Jee Hyun Kim

Publication type:

Article

Locoregional Recurrence by Tumor Biology in Breast Cancer Patients after Preoperative Chemotherapy and Breast Conservation Treatment.

Published in:

Cancer Research & Treatment, 2016, v. 48, n. 4, p. 1363, doi. 10.4143/crt.2015.456

By:

Eunjin Jwa;
Kyung Hwan Shin;
Ja Young Kim;
Young Hee Park;
So-Youn Jung;
Eun Sook Lee;
In Hae Park;
Keun Seok Lee;
Jungsil Ro;
Yeon-Joo Kim;
Tae Hyun Kim

Publication type:

Article

Survival Outcome of Combined GnRH Agonist and Tamoxifen Is Comparable to That of Sequential Adriamycin and Cyclophosphamide Chemotherapy Plus Tamoxifen in Premenopausal Patients with Lymph-Node-Negative, Hormone-Responsive, HER2-Negative, T1-T2 Breast Cancer

Published in:

Cancer Research & Treatment, 2016, v. 48, n. 4, p. 1351, doi. 10.4143/crt.2015.444

By:

Guiyun Sohn;
Sei Hyun Ahn;
Hee Jeong Kim;
Byung-Ho Son;
Jong Won Lee;
Beom Seok Ko;
Yura Lee;
Sae Byul Lee;
Seunghee Baek

Publication type:

Article

Caveolin-1 Modulates Docetaxel-Induced Cell Death in Breast Cancer Cell Subtypes through Different Mechanisms.

Published in:

Cancer Research & Treatment, 2016, v. 48, n. 2, p. 715, doi. 10.4143/crt.2015.227

By:

Jinho Kang;
Joo Hee Park;
Hye Jin Lee;
Ukhyun Jo;
Jong Kuk Park;
Jae Hong Seo;
Yeul Hong Kim;
Insun Kim;
Kyong Hwa Park

Publication type:

Article

Trastuzumab for Her2/neu-positive metastatic salivary gland carcinoma: Case report and review of the literature.

Published in:

2012

By:

Firwana, Belal;
Atassi, Bassel;
Hasan, Rim;
Hasan, Nour;
Sukari, Ammar

Publication type:

Case Study

Lead exposure and plasma mRNA expression in ERBB2 gene.

Published in:

Molecular Medicine Reports, 2017, v. 15, n. 5, p. 3361, doi. 10.3892/mmr.2017.6382

By:

FERRANTE, MARGHERITA;
LEDDA, CATERINA;
CONTI, GEA OLIVERI;
FIORE, MARIA;
RAPISARDA, VENERANDO;
COPAT, CHIARA;
SOLE, GIUSEPPE;
TERZO, NIVEA;
TRAVALI, SALVATORE

Publication type:

Article

Type II cGMP-dependent protein kinase directly inhibits HER2 activation of gastric cancer cells.

Published in:

Molecular Medicine Reports, 2016, v. 13, n. 2, p. 1909, doi. 10.3892/mmr.2015.4688

By:

MIAOLIN ZHU;
XIAOYUAN YAO;
MIN WU;
HAI QIAN;
YAN WU;
YONGCHANG CHEN

Publication type:

Article

Reduced expression of HSP27 following HAD-B treatment is associated with Her2 downregulation in NIH:OVCAR-3 human ovarian cancer cells.

Published in:

Molecular Medicine Reports, 2015, v. 12, n. 3, p. 3787, doi. 10.3892/mmr.2015.3876

By:

KUO CHU LI;
KYUN HEO;
AMBADE, NITIN;
MIN KYUNG KIM;
KYUNG-HEE KIM;
BYONG CHUL YOO;
HWA-SEUNG YOO

Publication type:

Article

Role of HER-2 activity in the regulation of malignant meningioma cell proliferation and motility.

Published in:

Molecular Medicine Reports, 2015, v. 12, n. 3, p. 3575, doi. 10.3892/mmr.2015.3805

By:

WEIJIA WANG;
YI TU;
SHANSHAN WANG;
SHAN XU;
LINLIN XU;
YIFENG XIONG;
JINHONG MEI;
CHUNLIANG WANG

Publication type:

Article

Fully human HER2/cluster of differentiation 3 bispecific antibody triggers potent and specific cytotoxicity of T lymphocytes against breast cancer.

Published in:

Molecular Medicine Reports, 2015, v. 12, n. 1, p. 147, doi. 10.3892/mmr.2015.3441

By:

YAN ZHOU;
LAN-TU GOU;
ZHI-HUI GUO;
HAI-RONG LIU;
JIANG-MAN WANG;
SHU-XIAN ZHOU;
JIN-LIANG YANG;
XIAO-AN LI

Publication type:

Article

Second-Line Treatment of HER2-Positive Salivary Gland Tumor: Ado-Trastuzumab Emtansine (T-DM1) after Progression on Trastuzumab.

Published in:

Case Reports in Oncology, 2018, v. 11, n. 2, p. 252, doi. 10.1159/000488669

By:

Strava Corrêa, Tatiana;
Ramos Matos, Gustavo Duarte;
Segura, Marcos;
dos Anjos, Carlos Henrique

Publication type:

Article

Complete and Sustained Response with a Doublet Chemotherapy Protocol in an 81-Year-Old Patient with Metastatic Breast Cancer.

Published in:

Case Reports in Oncology, 2016, v. 9, n. 3, p. 580, doi. 10.1159/000449127

By:

Puty, Taynah Cascaes;
Brito, Gabriel S.A.;
Dias, Mariana S.;
Miranda, Henrique C.;
Chaves, Juliana R.;
Freitas, Heryvelton L.;
Carvalho, Luís E.W.

Publication type:

Article

Intra-tumoral spatial heterogeneity in breast cancer quantified using high-dimensional protein multiplexing and single cell phenotyping.

Published in:

Breast Cancer Research, 2025, v. 27, n. 1, p. 1, doi. 10.1186/s13058-025-02038-1

By:

Cheung, Alison M.;
Wang, Dan;
Quintayo, Mary Anne;
Yerofeyeva, Yulia;
Spears, Melanie;
Bartlett, John M. S.;
Stein, Lincoln;
Bayani, Jane;
Yaffe, Martin J.

Publication type:

Article

An ERBB3/ ERBB2 oncogenic unit plays a key role in NRG1 signaling and melanoma cell growth and survival.

Published in:

Pigment Cell & Melanoma Research, 2013, v. 26, n. 3, p. 408, doi. 10.1111/pcmr.12089

By:

Zhang, Keman;
Wong, Poki;
Duan, Jiaqi;
Jacobs, Barbara;
Borden, Ernest C.;
Bedogni, Barbara

Publication type:

Article